- ¥5bn
- ¥1bn
- ¥7bn
- 91
- 78
- 52
- 88
Annual income statement for CNS Co, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,578 | 4,841 | 5,419 | 5,989 | 6,657 |
Cost of Revenue | |||||
Gross Profit | 973 | 1,148 | 1,322 | 1,506 | 1,639 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,146 | 4,389 | 4,886 | 5,430 | 6,051 |
Operating Profit | 432 | 452 | 533 | 559 | 606 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 481 | 483 | 595 | 589 | 636 |
Provision for Income Taxes | |||||
Net Income After Taxes | 325 | 337 | 409 | 433 | 461 |
Net Income Before Extraordinary Items | |||||
Net Income | 325 | 337 | 409 | 433 | 461 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 325 | 337 | 409 | 433 | 461 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 116 | 121 | 141 | 149 | 162 |
Dividends per Share | |||||
Special Dividends per Share |